Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anja Lorch

Showing results (1-10 of 79) with videos related to

Pageof 8
Sort By:
The Lancet. Oncology|December 3, 2014
A practice-changing step forward in germ-cell cancer?Anja Lorch
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|September 21, 2018
Management of Refractory Germ Cell CancerAnja Lorch
Cancer|May 18, 2017
How we treat germ cell cancersAnja Lorch, Jörg Beyer
Oncology Research and Treatment|May 30, 2018
The Role of Salvage High-Dose Chemotherapy in Relapsed Male Germ Cell TumorsChristoph Oing, Anja Lorch
World Journal of Urology|September 29, 2016
High-dose chemotherapy as salvage treatment in germ-cell cancer: when, in whom and howAnja Lorch, Jörg Beyer
Onkologie|September 17, 2011
[Solid tumors in young patients]Jörg T Hartmann, Anja Lorch
The New England Journal of Medicine|October 31, 2007
Germ-cell tumorsAnja Lorch, Jörg Beyer, Carsten Bokemeyer
Hematology/Oncology Clinics of North America|May 17, 2011
Late relapse of germ cell tumorsJan Oldenburg, Anja Lorch, Sophie D Fosså
Journal of Cancer Research and Clinical Oncology|May 4, 2013
Prognostic impact of LDH levels in patients with relapsed/refractory seminomaTom Powles, Caroline Bascoul-Mollevi, Andrew Kramar, et al.
Cancers|April 3, 2020
Non-Coding microRNAs as Novel Potential Tumor Markers in Testicular CancerManuel Regouc, Gazanfer Belge, Anja Lorch, et al.
Pageof 8

Showing results (1-10 of 79) with videos related to

Sort By:
Pageof 8
The Lancet. Oncology|December 3, 2014
A practice-changing step forward in germ-cell cancer?Anja Lorch
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|September 21, 2018
Management of Refractory Germ Cell CancerAnja Lorch
Cancer|May 18, 2017
How we treat germ cell cancersAnja Lorch, Jörg Beyer
Oncology Research and Treatment|May 30, 2018
The Role of Salvage High-Dose Chemotherapy in Relapsed Male Germ Cell TumorsChristoph Oing, Anja Lorch
World Journal of Urology|September 29, 2016
High-dose chemotherapy as salvage treatment in germ-cell cancer: when, in whom and howAnja Lorch, Jörg Beyer
Onkologie|September 17, 2011
[Solid tumors in young patients]Jörg T Hartmann, Anja Lorch
The New England Journal of Medicine|October 31, 2007
Germ-cell tumorsAnja Lorch, Jörg Beyer, Carsten Bokemeyer
Hematology/Oncology Clinics of North America|May 17, 2011
Late relapse of germ cell tumorsJan Oldenburg, Anja Lorch, Sophie D Fosså
Journal of Cancer Research and Clinical Oncology|May 4, 2013
Prognostic impact of LDH levels in patients with relapsed/refractory seminomaTom Powles, Caroline Bascoul-Mollevi, Andrew Kramar, et al.
Cancers|April 3, 2020
Non-Coding microRNAs as Novel Potential Tumor Markers in Testicular CancerManuel Regouc, Gazanfer Belge, Anja Lorch, et al.
Pageof 8